Pharmacological analysis of the haemodynamic effects of 5‐HT 1B/D receptor agonists in the normotensive rat
The receptors involved in mediating the haemodynamic effects of three 5‐HT 1B/D receptor agonists were investigated in pentobarbitone anaesthetized rats ( n =6–17 per group). Cumulative intravenous (i.v.) infusions of rizatriptan and sumatriptan (from 0.63 to 2500 μg kg −1 ; each dose over 5 min) in...
Gespeichert in:
Veröffentlicht in: | British journal of pharmacology 2009-02, Vol.123 (2), p.205-214 |
---|---|
Hauptverfasser: | , , , , |
Format: | Artikel |
Sprache: | eng |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 214 |
---|---|
container_issue | 2 |
container_start_page | 205 |
container_title | British journal of pharmacology |
container_volume | 123 |
creator | Pagniez, Fabrice Valentin, Jean‐Pierre Vieu, Sylvie Colpaert, Francis C John, Gareth W |
description | The receptors involved in mediating the haemodynamic effects of three 5‐HT
1B/D
receptor agonists were investigated in pentobarbitone anaesthetized rats (
n
=6–17 per group).
Cumulative intravenous (i.v.) infusions of rizatriptan and sumatriptan (from 0.63 to 2500 μg kg
−1
; each dose over 5 min) induced dose‐dependent and marked hypotension (−42±6 and −34±4 mmHg at the highest dose, respectively; both
P |
doi_str_mv | 10.1038/sj.bjp.0701593 |
format | Article |
fullrecord | <record><control><sourceid>crossref</sourceid><recordid>TN_cdi_crossref_primary_10_1038_sj_bjp_0701593</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>10_1038_sj_bjp_0701593</sourcerecordid><originalsourceid>FETCH-LOGICAL-c843-7f8aba19fe50720e94ccddd43b3519c9467742a3bf9827aa44ef7f4b9c63da1a3</originalsourceid><addsrcrecordid>eNotkL1OwzAUhS0EEqWwMvsFktq1E9sjlJ8iVYIhe3TjXLeOkriyI6RuPALPyJNQSqczfOec4SPknrOcM6EXqcubbp8zxXhhxAWZcanKrBCaX5IZY0xlnGt9TW5S6hg7QlXMyPCxgziADX3Yegs9hRH6Q_KJBkenHdId4BDawwiDtxSdQzudWPHz9b2uKH9cPNGIFvdTiBS2YfTpWPDjaTyGOIQJx-Q_kUaYbsmVgz7h3TnnpHp5rlbrbPP--rZ62GRWS5Epp6EBbhwWTC0ZGmlt27ZSNKLgxhpZKiWXIBpn9FIBSIlOOdkYW4oWOIg5yf9vbQwpRXT1PvoB4qHmrP5zVaeuPrqqz67EL7ESYH0</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Pharmacological analysis of the haemodynamic effects of 5‐HT 1B/D receptor agonists in the normotensive rat</title><source>Wiley Online Library Journals Frontfile Complete</source><source>Wiley Online Library Free Content</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>PubMed Central</source><source>Alma/SFX Local Collection</source><creator>Pagniez, Fabrice ; Valentin, Jean‐Pierre ; Vieu, Sylvie ; Colpaert, Francis C ; John, Gareth W</creator><creatorcontrib>Pagniez, Fabrice ; Valentin, Jean‐Pierre ; Vieu, Sylvie ; Colpaert, Francis C ; John, Gareth W</creatorcontrib><description><![CDATA[The receptors involved in mediating the haemodynamic effects of three 5‐HT
1B/D
receptor agonists were investigated in pentobarbitone anaesthetized rats (
n
=6–17 per group).
Cumulative intravenous (i.v.) infusions of rizatriptan and sumatriptan (from 0.63 to 2500 μg kg
−1
; each dose over 5 min) induced dose‐dependent and marked hypotension (−42±6 and −34±4 mmHg at the highest dose, respectively; both
P
<0.05 vs vehicle: +5±3 mmHg) and bradycardia (−85±16 and −44±12 beats min
−1
at the highest dose, respectively; both
P
<0.05 vs vehicle: +16±6 beats min
−1
). Zolmitriptan evoked only moderate hypotension at the highest dose (−19±9 mmHg;
P
<0.05 vs vehicle).
A high dose of the 5‐HT
1B/D
receptor antagonist, GR 127935 (0.63 mg kg
−1
, i.v.), failed to antagonize the hypotension and bradycardia evoked by sumatriptan (−35±6 mmHg and −52±19 beats min
−1
, respectively; both not significant vs sumatriptan in untreated rats), but moderately reduced the hypotension and bradycardia evoked by rizatriptan (−20±5 mmHg and −30±17 beats min
−1
, respectively; both
P
<0.05 vs vehicle and vs rizatriptan in untreated rats).
The selective 5‐HT
1A
receptor antagonist, WAY 100635 (0.16 and 0.63 mg kg
−1
, i.v.), dose‐dependently attenuated the haemodynamic responses evoked by rizatriptan and sumatriptan, which were almost abolished by the higher dose of WAY 100635 (−4±3 mmHg and −15±8 beats min
−1
; both not significant vs vehicle and
P
<0.05 vs rizatriptan in untreated rats). A slight but statistically significant reduction in mean arterial pressure (MAP) persisted at the highest dose of sumatriptan (−13±4 mmHg following the higher dose of WAY 100635;
P
<0.05 vs vehicle).
In pithed rats with MAP normalized by angiotensin II, rizatriptan failed to induce hypotension or bradycardia (+5±4 mmHg and −6±16 beats min
−1
, respectively; both NS vs vehicle and
P
<0.05 vs rizatriptan in untreated rats). Similarly, sumatriptan failed to induce bradycardia in pithed rats (+5±6 beats min
−1
; not significant vs vehicle and
P
<0.05 vs sumatriptan in untreated rats), whereas a slight but statistically significant reduction in MAP, compared to controls, occurred at the highest dose (−9±9 mmHg;
P
<0.05 vs both vehicle and sumatriptan in untreated rats).
In bilaterally vagotomized and atropine‐treated (1 mg kg
−1
, i.v.) rats, the reductions in MAP and heart rate evoked by rizatriptan (−31±4 mmHg and −64 ±9 beats min
−1
, respectively; both
P
<0.05 vs vehicle and not significant vs rizatriptan in controls) and sumatriptan (−47±8 mmHg and −56±10 beats min
−1
, respectively; both
P
<0.05 vs vehicle and not significant vs sumatriptan in controls) were not statistically significantly different from those observed in controls.
In conclusion, the 5‐HT
1B/D
receptor agonists, rizatriptan and sumatriptan, elicit hypotension and bradycardia in the normotensive anaesthetized rat predominantly via activation of central 5‐HT
1A
receptors, and a consequent reduction in sympathetic outflow.
British Journal of Pharmacology
(1998)
123
, 205–214; doi:
10.1038/sj.bjp.0701593]]></description><identifier>ISSN: 0007-1188</identifier><identifier>EISSN: 1476-5381</identifier><identifier>DOI: 10.1038/sj.bjp.0701593</identifier><language>eng</language><ispartof>British journal of pharmacology, 2009-02, Vol.123 (2), p.205-214</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c843-7f8aba19fe50720e94ccddd43b3519c9467742a3bf9827aa44ef7f4b9c63da1a3</citedby><cites>FETCH-LOGICAL-c843-7f8aba19fe50720e94ccddd43b3519c9467742a3bf9827aa44ef7f4b9c63da1a3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids></links><search><creatorcontrib>Pagniez, Fabrice</creatorcontrib><creatorcontrib>Valentin, Jean‐Pierre</creatorcontrib><creatorcontrib>Vieu, Sylvie</creatorcontrib><creatorcontrib>Colpaert, Francis C</creatorcontrib><creatorcontrib>John, Gareth W</creatorcontrib><title>Pharmacological analysis of the haemodynamic effects of 5‐HT 1B/D receptor agonists in the normotensive rat</title><title>British journal of pharmacology</title><description><![CDATA[The receptors involved in mediating the haemodynamic effects of three 5‐HT
1B/D
receptor agonists were investigated in pentobarbitone anaesthetized rats (
n
=6–17 per group).
Cumulative intravenous (i.v.) infusions of rizatriptan and sumatriptan (from 0.63 to 2500 μg kg
−1
; each dose over 5 min) induced dose‐dependent and marked hypotension (−42±6 and −34±4 mmHg at the highest dose, respectively; both
P
<0.05 vs vehicle: +5±3 mmHg) and bradycardia (−85±16 and −44±12 beats min
−1
at the highest dose, respectively; both
P
<0.05 vs vehicle: +16±6 beats min
−1
). Zolmitriptan evoked only moderate hypotension at the highest dose (−19±9 mmHg;
P
<0.05 vs vehicle).
A high dose of the 5‐HT
1B/D
receptor antagonist, GR 127935 (0.63 mg kg
−1
, i.v.), failed to antagonize the hypotension and bradycardia evoked by sumatriptan (−35±6 mmHg and −52±19 beats min
−1
, respectively; both not significant vs sumatriptan in untreated rats), but moderately reduced the hypotension and bradycardia evoked by rizatriptan (−20±5 mmHg and −30±17 beats min
−1
, respectively; both
P
<0.05 vs vehicle and vs rizatriptan in untreated rats).
The selective 5‐HT
1A
receptor antagonist, WAY 100635 (0.16 and 0.63 mg kg
−1
, i.v.), dose‐dependently attenuated the haemodynamic responses evoked by rizatriptan and sumatriptan, which were almost abolished by the higher dose of WAY 100635 (−4±3 mmHg and −15±8 beats min
−1
; both not significant vs vehicle and
P
<0.05 vs rizatriptan in untreated rats). A slight but statistically significant reduction in mean arterial pressure (MAP) persisted at the highest dose of sumatriptan (−13±4 mmHg following the higher dose of WAY 100635;
P
<0.05 vs vehicle).
In pithed rats with MAP normalized by angiotensin II, rizatriptan failed to induce hypotension or bradycardia (+5±4 mmHg and −6±16 beats min
−1
, respectively; both NS vs vehicle and
P
<0.05 vs rizatriptan in untreated rats). Similarly, sumatriptan failed to induce bradycardia in pithed rats (+5±6 beats min
−1
; not significant vs vehicle and
P
<0.05 vs sumatriptan in untreated rats), whereas a slight but statistically significant reduction in MAP, compared to controls, occurred at the highest dose (−9±9 mmHg;
P
<0.05 vs both vehicle and sumatriptan in untreated rats).
In bilaterally vagotomized and atropine‐treated (1 mg kg
−1
, i.v.) rats, the reductions in MAP and heart rate evoked by rizatriptan (−31±4 mmHg and −64 ±9 beats min
−1
, respectively; both
P
<0.05 vs vehicle and not significant vs rizatriptan in controls) and sumatriptan (−47±8 mmHg and −56±10 beats min
−1
, respectively; both
P
<0.05 vs vehicle and not significant vs sumatriptan in controls) were not statistically significantly different from those observed in controls.
In conclusion, the 5‐HT
1B/D
receptor agonists, rizatriptan and sumatriptan, elicit hypotension and bradycardia in the normotensive anaesthetized rat predominantly via activation of central 5‐HT
1A
receptors, and a consequent reduction in sympathetic outflow.
British Journal of Pharmacology
(1998)
123
, 205–214; doi:
10.1038/sj.bjp.0701593]]></description><issn>0007-1188</issn><issn>1476-5381</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2009</creationdate><recordtype>article</recordtype><recordid>eNotkL1OwzAUhS0EEqWwMvsFktq1E9sjlJ8iVYIhe3TjXLeOkriyI6RuPALPyJNQSqczfOec4SPknrOcM6EXqcubbp8zxXhhxAWZcanKrBCaX5IZY0xlnGt9TW5S6hg7QlXMyPCxgziADX3Yegs9hRH6Q_KJBkenHdId4BDawwiDtxSdQzudWPHz9b2uKH9cPNGIFvdTiBS2YfTpWPDjaTyGOIQJx-Q_kUaYbsmVgz7h3TnnpHp5rlbrbPP--rZ62GRWS5Epp6EBbhwWTC0ZGmlt27ZSNKLgxhpZKiWXIBpn9FIBSIlOOdkYW4oWOIg5yf9vbQwpRXT1PvoB4qHmrP5zVaeuPrqqz67EL7ESYH0</recordid><startdate>20090203</startdate><enddate>20090203</enddate><creator>Pagniez, Fabrice</creator><creator>Valentin, Jean‐Pierre</creator><creator>Vieu, Sylvie</creator><creator>Colpaert, Francis C</creator><creator>John, Gareth W</creator><scope>AAYXX</scope><scope>CITATION</scope></search><sort><creationdate>20090203</creationdate><title>Pharmacological analysis of the haemodynamic effects of 5‐HT 1B/D receptor agonists in the normotensive rat</title><author>Pagniez, Fabrice ; Valentin, Jean‐Pierre ; Vieu, Sylvie ; Colpaert, Francis C ; John, Gareth W</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c843-7f8aba19fe50720e94ccddd43b3519c9467742a3bf9827aa44ef7f4b9c63da1a3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2009</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Pagniez, Fabrice</creatorcontrib><creatorcontrib>Valentin, Jean‐Pierre</creatorcontrib><creatorcontrib>Vieu, Sylvie</creatorcontrib><creatorcontrib>Colpaert, Francis C</creatorcontrib><creatorcontrib>John, Gareth W</creatorcontrib><collection>CrossRef</collection><jtitle>British journal of pharmacology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Pagniez, Fabrice</au><au>Valentin, Jean‐Pierre</au><au>Vieu, Sylvie</au><au>Colpaert, Francis C</au><au>John, Gareth W</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Pharmacological analysis of the haemodynamic effects of 5‐HT 1B/D receptor agonists in the normotensive rat</atitle><jtitle>British journal of pharmacology</jtitle><date>2009-02-03</date><risdate>2009</risdate><volume>123</volume><issue>2</issue><spage>205</spage><epage>214</epage><pages>205-214</pages><issn>0007-1188</issn><eissn>1476-5381</eissn><abstract><![CDATA[The receptors involved in mediating the haemodynamic effects of three 5‐HT
1B/D
receptor agonists were investigated in pentobarbitone anaesthetized rats (
n
=6–17 per group).
Cumulative intravenous (i.v.) infusions of rizatriptan and sumatriptan (from 0.63 to 2500 μg kg
−1
; each dose over 5 min) induced dose‐dependent and marked hypotension (−42±6 and −34±4 mmHg at the highest dose, respectively; both
P
<0.05 vs vehicle: +5±3 mmHg) and bradycardia (−85±16 and −44±12 beats min
−1
at the highest dose, respectively; both
P
<0.05 vs vehicle: +16±6 beats min
−1
). Zolmitriptan evoked only moderate hypotension at the highest dose (−19±9 mmHg;
P
<0.05 vs vehicle).
A high dose of the 5‐HT
1B/D
receptor antagonist, GR 127935 (0.63 mg kg
−1
, i.v.), failed to antagonize the hypotension and bradycardia evoked by sumatriptan (−35±6 mmHg and −52±19 beats min
−1
, respectively; both not significant vs sumatriptan in untreated rats), but moderately reduced the hypotension and bradycardia evoked by rizatriptan (−20±5 mmHg and −30±17 beats min
−1
, respectively; both
P
<0.05 vs vehicle and vs rizatriptan in untreated rats).
The selective 5‐HT
1A
receptor antagonist, WAY 100635 (0.16 and 0.63 mg kg
−1
, i.v.), dose‐dependently attenuated the haemodynamic responses evoked by rizatriptan and sumatriptan, which were almost abolished by the higher dose of WAY 100635 (−4±3 mmHg and −15±8 beats min
−1
; both not significant vs vehicle and
P
<0.05 vs rizatriptan in untreated rats). A slight but statistically significant reduction in mean arterial pressure (MAP) persisted at the highest dose of sumatriptan (−13±4 mmHg following the higher dose of WAY 100635;
P
<0.05 vs vehicle).
In pithed rats with MAP normalized by angiotensin II, rizatriptan failed to induce hypotension or bradycardia (+5±4 mmHg and −6±16 beats min
−1
, respectively; both NS vs vehicle and
P
<0.05 vs rizatriptan in untreated rats). Similarly, sumatriptan failed to induce bradycardia in pithed rats (+5±6 beats min
−1
; not significant vs vehicle and
P
<0.05 vs sumatriptan in untreated rats), whereas a slight but statistically significant reduction in MAP, compared to controls, occurred at the highest dose (−9±9 mmHg;
P
<0.05 vs both vehicle and sumatriptan in untreated rats).
In bilaterally vagotomized and atropine‐treated (1 mg kg
−1
, i.v.) rats, the reductions in MAP and heart rate evoked by rizatriptan (−31±4 mmHg and −64 ±9 beats min
−1
, respectively; both
P
<0.05 vs vehicle and not significant vs rizatriptan in controls) and sumatriptan (−47±8 mmHg and −56±10 beats min
−1
, respectively; both
P
<0.05 vs vehicle and not significant vs sumatriptan in controls) were not statistically significantly different from those observed in controls.
In conclusion, the 5‐HT
1B/D
receptor agonists, rizatriptan and sumatriptan, elicit hypotension and bradycardia in the normotensive anaesthetized rat predominantly via activation of central 5‐HT
1A
receptors, and a consequent reduction in sympathetic outflow.
British Journal of Pharmacology
(1998)
123
, 205–214; doi:
10.1038/sj.bjp.0701593]]></abstract><doi>10.1038/sj.bjp.0701593</doi><tpages>10</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0007-1188 |
ispartof | British journal of pharmacology, 2009-02, Vol.123 (2), p.205-214 |
issn | 0007-1188 1476-5381 |
language | eng |
recordid | cdi_crossref_primary_10_1038_sj_bjp_0701593 |
source | Wiley Online Library Journals Frontfile Complete; Wiley Online Library Free Content; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; PubMed Central; Alma/SFX Local Collection |
title | Pharmacological analysis of the haemodynamic effects of 5‐HT 1B/D receptor agonists in the normotensive rat |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-02T22%3A26%3A58IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-crossref&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Pharmacological%20analysis%20of%20the%20haemodynamic%20effects%20of%205%E2%80%90HT%201B/D%20receptor%20agonists%20in%20the%20normotensive%20rat&rft.jtitle=British%20journal%20of%20pharmacology&rft.au=Pagniez,%20Fabrice&rft.date=2009-02-03&rft.volume=123&rft.issue=2&rft.spage=205&rft.epage=214&rft.pages=205-214&rft.issn=0007-1188&rft.eissn=1476-5381&rft_id=info:doi/10.1038/sj.bjp.0701593&rft_dat=%3Ccrossref%3E10_1038_sj_bjp_0701593%3C/crossref%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |